© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Valion Bio, Inc. (VBIO) shows an Average True Range (ATR) of N/A and an Enterprise Value of N/A. Its average trading volume over the past 3 months is N/A, indicating liquidity. These fundamental metrics provide insight into VBIO's underlying financial health and market activity.
| ATR | N/A |
| Enterprise Value | - |
| Avg Vol (3 Months) | - |
| Avg Vol (10 Days) | - |
Valion Bio, Inc. (VBIO) technical indicators as of August 16, 2026: the SMA 20 is N/A, SMA 50 at N/A, and SMA 200 at N/A. The RSI 14 value is N/A, suggesting its current momentum. These technical analysis signals help assess VBIO's price trends and potential future movements.
| SMA 20 | N/A |
| SMA 50 | N/A |
| SMA 200 | N/A |
| RSI 14 | N/A |
Valion Bio, Inc. (VBIO) stock performance overview as of August 16, 2026: The 52-week high is $1.3 (currently N/A below), and the 52-week low is $0.159 (currently N/A above). Over the past year, VBIO's performance is N/A, compared to the S&P 500's 2.11% change.
| 52-Week High | 1.3 |
| 52-Week High Chg | - |
| 52-Week Low | 0.1594 |
| 52-Week Low Chg | - |
| S&P 500 52-Week Chg | 2.11% |
According to market data, Valion Bio, Inc. (VBIO) stock's recent performance metrics show that over the last month, VBIO is N/A, with a Year-to-Date (YTD) performance of N/A. Over the past year, the stock has seen a N/A change. These figures summarize VBIO's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 |
| Low | 0.1594 | 0.1594 | 0.1594 | 0.1594 | 0.1594 | 0.1594 |
| Performance | - | - | - | - | - | - |
According to current financial data, VBIO stock's P/E (TTM) ratio is -3.81, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for VBIO, including P/S (0.42), P/B (1.01), and P/FCF (-0.24), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | VBIO | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -3.81 | -1.24 | -193.07 | 32.59 |
| P/S (TTM) | 0.42 | 3.71 | 464.88 | 5.98 |
| P/B (TTM) | 1.01 | 1.21 | -3431.93 | 5.9 |
| P/FCF (TTM) | -0.24 | -1.2 | -650.44 | 33.4 |